Previous Close | 67.86 |
Open | 67.77 |
Bid | 67.72 x 200 |
Ask | 67.76 x 200 |
Day's Range | 67.21 - 67.82 |
52 Week Range | 64.33 - 87.87 |
Volume | |
Avg. Volume | 6,969,104 |
Market Cap | 84.369B |
Beta (5Y Monthly) | 0.23 |
PE Ratio (TTM) | 188.11 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.08 (4.54%) |
Ex-Dividend Date | Jun 14, 2024 |
1y Target Est | N/A |
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)